China-made Tamiflu approved for production
13/6/2006 17:13
A Chinese company has been approved by the State Food and Drug
Administration (SFDA) to produce the anti-flu drug, Tamiflu, sources with the
SFDA said today.
Tamiflu is an anti-viral drug which is considered the most
effective treatment available to counter the H5N1 strain of bird flu.
Swiss
pharmaceutical firm Roche Swiss granted a sub-license for the production of
Tamiflu to the Shanghai Pharmaceutical Group in December. Clinical studies on
the effectiveness of Tamiflu began in March.
Xinhua News
|
